Altimmune (ALT) EBITDA Margin (2009 - 2025)
Altimmune (ALT) reported EBITDA Margin of -111026.92% for Q4 2025, up 385633.08 percentage points from -496660.00% a year earlier and up 305613.08 percentage points from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) EBITDA Margin (2009 - 2025) Analysis & Trends
For FY2025, Altimmune posted EBITDA Margin of -230187.80%, up 284482.20 percentage points from FY2024.
- EBITDA Margin has a five-year change of -229523.54 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -514670.00% in FY2024 (-492268.83 pp), -22401.17% in FY2023 (+106929.71 pp), -129330.88% in FY2022 (-127145.78 pp) and -2185.10% in FY2021 (-1520.84 pp).
- The Q4 2025 figure ranks as the highest quarterly EBITDA Margin since Q4 2023.
- Year over year, EBITDA Margin has now increased in each of the last four quarters, with an average year-over-year change of -113812.79 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q3 2023 (a gain of 1238270.99 percentage points); the low point was Q3 2022 (a drop of 1223815.19 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -416640.00% (Q3 2025), -457840.00% (Q2 2025) and -435720.00% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Altimmune | 377.28 Mn | -764.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -110,288.46% |
| Sep 30, 2025 | -414,380.00% |
| Jun 30, 2025 | -457,840.00% |
| Mar 31, 2025 | -435,720.00% |
| Dec 31, 2024 | -496,660.00% |
| Sep 30, 2024 | -494,600.00% |
| Jun 30, 2024 | -533,680.00% |
| Mar 31, 2024 | -533,740.00% |
| Dec 31, 2023 | -90,502.70% |
| Sep 30, 2023 | -6,379.01% |
| Jun 30, 2023 | -308,533.33% |
| Mar 31, 2023 | -105,309.52% |
| Dec 31, 2022 | -89,730.77% |
| Sep 30, 2022 | -1,244,650.00% |
| Jun 30, 2022 | -254,275.00% |
| Mar 31, 2022 | -60,562.50% |
| Dec 31, 2021 | -728.35% |
| Sep 30, 2021 | -20,834.81% |
| Jun 30, 2021 | -18,094.16% |
| Mar 31, 2021 | -1,764.56% |
API Access
Altimmune EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();